The 8th annual EBD Biotech showcase takes place this week, from January 11-13, in San Francisco, CA.
With over 1,500 attending companies and over 2,000 attendees, the showcase is a leading networking meeting that brings together private and public sector biotechnology companies and investors.
Akron Biotech will be at the conference – our attendance will also be marked by a company presentation highlighting our innovative technologies, services, capabilities and strategic parnerships.
Attendees will hear about our new products which includes the launch of the industry’s first virus inactivated fibronectin from human plasma, human serum albumin and our continually-innovating line of DMSO-free cryopreservation media, Cryonovo.
The presentation will take place on Monday, January 11th at 10:15 am in the Davison Room.
For more information, visit this page.